Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avrobio Inc
(NQ:
AVRO
)
1.400
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.400
Bid (Size)
1.390 (1)
Ask (Size)
1.460 (3)
Prev. Close
1.400
Today's Range
1.400 - 1.400
52wk Range
12.12 - 19.80
Shares Outstanding
44,105,078
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PLTR Stock: Palantir Bags New Partnership With ARPA-H for AI/ML
June 20, 2024
Palantir stock is on the rise Thursday as PLTR investors react to a new $19 million contract for the big data and AI company.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today?
June 20, 2024
NLS Pharmaceutics stock is down on Thursday as shares of NLSP come off of a recent rally that was fueled by heavy trading on Tuesday.
Via
InvestorPlace
Performance
YTD
-91.90%
-91.90%
1 Month
N/A
N/A
3 Month
-91.61%
-91.61%
6 Month
-91.03%
-91.03%
1 Year
-92.27%
-92.27%
More News
Read More
Why Is Avrobio (AVRO) Stock Moving Today?
June 20, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 20, 2024
Via
InvestorPlace
AVRO Stock Earnings: Avrobio Beats EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
Why Avrobio Shares Are Rising Wednesday
July 12, 2023
Via
Benzinga
Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis
May 22, 2023
Via
Benzinga
AVROBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO
May 09, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AVROBIO, Inc. (Nasdaq – AVRO), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), California BanCorp (Nasdaq – CALB)
February 26, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HireRight Holdings Corporation (NYSE – HRT), Kinnate Biopharma Inc. (Nasdaq – KNTE), AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB)
February 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO
February 14, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ZeroFox Holdings, Inc. (Nasdaq – ZFOX), AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB), Exro Technologies Inc. (OTC – EXROF)
February 06, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB), Exro Technologies Inc. (OTC – EXROF), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
January 30, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to Shareholders
January 30, 2024
From
Halper Sadeh LLC
Via
Business Wire
AVROBIO and Tectonic Therapeutic Announce Merger
January 30, 2024
From
AVROBIO, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 12, 2023
Via
Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 12, 2023
Via
Benzinga
AVROBIO to Explore Strategic Alternatives
July 12, 2023
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million
June 12, 2023
From
AVROBIO, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 07, 2023
Via
Benzinga
Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis
May 22, 2023
Via
Benzinga
Dow Tumbles 100 Points; Micron Technology Shares Plunge
May 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 22, 2023
Via
Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 22, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.